Breast cancer is the most common today, however medical findings have begun to show encouraging.
After years of extensive scientific research, a vaccine was developed that is intended to treat breast cancer. The invention was made by the Mayo Clinic and during the first trial it demonstrated efficient results.
The clinical trial was carried out with Lee Mercker, an American patient who had been diagnosed with the disease. The specialists decided to present the proposal to him because the cancer was in an early stage and the treatment had not started. metastasis.
Thus, the woman made herself available to the medical center and carried out the treatment for 12 weeks. In that time period, he received a total of 7 doses.
After that, the analysis phase of this vaccine arrived. For that reason, the woman underwent rigorous laboratory tests and it was possible to visualize that the method had an influence to eliminate the malignant tumor.
However, Lee Marcker preferred to undergo a mastectomy, the process in which the woman’s breast is removed. This, with the intention of preventing breast cancer from evolving again in the future.
For their part, specialists from the Mayo Clinic stated that the procedure has begun to be performed in other patients who also show positive evolution. However, they acknowledge that the vaccine will continue to be investigated because the ultimate idea is that it works as a method that prevents the condition.
Current panorama of breast cancer
Statistics indicate that breast cancer is the one that most attacks the female gender; so much so, that in 2018 it was the most detected in Latin America. Additionally, 2.3 million women around the world were diagnosed in 2020, according to the World Health Organization.
These figures reveal that this cancer surpassed lung cancer and became the most common in the world today. Because of this, the first findings of the vaccine are a great deal of hope for the world’s population.
It might interest you …